INDIANAPOLIS, Jan 08, 2008 -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Cialis® (tadalafil)(1) for once daily use (2.5 mg and 5 ...

INDIANAPOLIS, Oct. 7, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Cialis® (tadalafil) tablets for once daily ...

Add Yahoo as a preferred source to see more of our stories on Google. recreational use of viagra and cialis It’s a big problem — and it’s growing even bigger. Social media users are being bombarded ...

Paris, January 21, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual use trial (AUT) to ...

Paris. May 30, 2022. The U.S. Food and Drug Administration has informed Sanofi that its planned Actual Use Trial (AUT) to support the Rx-to-OTC switch for Cialis® (tadalafil) has been placed on ...

Sanofi on Monday announced an actual use trial of its Cialis erectile dysfunction treatment was put on clinical hold in the United States by the Food and Drug Administration (FDA). PARIS, May 30 ...

Cialis OK'd to treat benign prostatic hyperplasia FDA has approved expanded use of Cialis Drug brought in 8% of Lilly's revenue INDIANAPOLIS (AP) — The European Union has approved Eli Lilly and Co.'s ...

Currently only available with a prescription, Cialis is a tablet taken to treat erectile dysfunction (ED), the signs and symptoms of benign prostatic hyperplasia (BPH), and both ED and the signs and ...